Literature DB >> 34275119

IFN-γ inhibits ovarian cancer progression via SOCS1/JAK/STAT signaling pathway.

A H Gao1, Y R Hu2, W P Zhu3.   

Abstract

PURPOSE: Ovarian cancer (OC) is a common malignancy, and IFN-γ, a multifunctional cytokine, is unveiled to impede the multiplication and enhance apoptosis in diverse tumor cells in previous research. Nonetheless, its function and mechanism in OC are blurred.
METHODS: OC cell lines SKOV3 and OVCAR3 were dealt with different concentrations (0-40 ng/ml) of IFN-γ. CCK-8 experiment was utilized to examine cell multiplication; Flow cytometry was executed to detect apoptosis and cell cycle; Wound healing assay was utilized to detect cell migration; and Transwell experiment was implemented to examine cell invasion. qRT-PCR analysis was applied to detect STAT5, STAT3, JAK2 and JAK3 mRNA expression in OC cell lines. Western blot experiment was applied to detect the protein and phosphorylation levels of SOCS1, STAT5 and STAT3.
RESULTS: IFN-γ suppressed OC cell multiplication in a concentration-dependent manner. Relative to the control group, IFN-γ restrained OC cell migration, invasion, enhanced apoptosis and prevented cell transformation from G0/G1 to S phase. Further analysis revealed that IFN-γ up-modulated SOCS1 expression and impeded STAT5 and STAT3 protein phosphorylation levels, and knockdown of SOCS1 partially counteracted the inhibitory effect of IFN-γ on STAT5 and STAT3 protein phosphorylation levels.
CONCLUSION: IFN-γ represses OC progression by facilitating SOCS1 to suppress STAT3 and STAT5 protein phosphorylation.
© 2021. Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  IFN-γ; JAK/STAT signaling pathway; Ovarian cancer; SOCS1

Mesh:

Substances:

Year:  2021        PMID: 34275119     DOI: 10.1007/s12094-021-02668-9

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  2 in total

1.  Identification of SOCS family members with prognostic values in human ovarian cancer.

Authors:  Mengqi Yang; Huanting Chen; Lin Zhou; Xiaobo Huang; Fengxi Su; Peng Wang
Journal:  Am J Transl Res       Date:  2020-05-15       Impact factor: 4.060

2.  IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro.

Authors:  Lucy Wall; Frances Burke; Caroline Barton; John Smyth; Fran Balkwill
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

  2 in total
  6 in total

1.  Investigation of Interferon Gamma Activity Using Bioinformatics Methods.

Authors:  N E Hassan; A A Al-Janabi
Journal:  Arch Razi Inst       Date:  2021-11-30

2.  IFNγ-induced PD-L1 expression in ovarian cancer cells is regulated by JAK1, STAT1 and IRF1 signaling.

Authors:  Sveta Padmanabhan; Bijaya Gaire; Yue Zou; Mohammad M Uddin; Ivana Vancurova
Journal:  Cell Signal       Date:  2022-07-09       Impact factor: 4.850

3.  Structure-Activity Relationship Investigations of Novel Constrained Chimeric Peptidomimetics of SOCS3 Protein Targeting JAK2.

Authors:  Sara La Manna; Marilisa Leone; Flavia Anna Mercurio; Daniele Florio; Daniela Marasco
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-09

4.  RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop.

Authors:  Chengwu Xiao; Wei Zhang; Meimian Hua; Huan Chen; Bin Yang; Ye Wang; Qing Yang
Journal:  Cell Mol Biol Lett       Date:  2022-05-13       Impact factor: 8.702

5.  Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway-Related Prognostic Prediction Model in Gastric Cancer.

Authors:  Fei Jiang; Xiaowei Chen; Yan Shen; Xiaobing Shen
Journal:  Front Genet       Date:  2022-07-19       Impact factor: 4.772

6.  The Comprehensive Analysis of Interferon-Related Prognostic Signature with regard to Immune Features in Ovarian Cancer.

Authors:  Yuanyuan An; Hua Duan
Journal:  Dis Markers       Date:  2022-06-20       Impact factor: 3.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.